Cryotherapy, a procedure that involves controlled tissue destruction through extreme cold, is widely acknowledged as the leading approach for removing skin lesions in dermatology and aesthetic practices.
The FreezPen, a device manufactured in Belgium and licensed by Health Canada, offers a safe, fast, and comfortable procedure without scarring or downtime. It utilizes Nitrous Oxide (N2O), which is a safer alternative to Liquid Nitrogen (N2) commonly used in other cryotherapy methods. By using N2O, the FreezPen can rapidly freeze and destroy targeted cells while maintaining a temperature that minimizes damage to surrounding healthy tissue. This precision is achieved through the FreezPen’s specially designed applicator, which ensures maximum accuracy during treatment by allowing for controlled gas outflow that specifically targets the lesion.